539 related articles for article (PubMed ID: 37934800)
1. Diabetes Mellitus, Energy Metabolism, and COVID-19.
Conte C; Cipponeri E; Roden M
Endocr Rev; 2024 Mar; 45(2):281-308. PubMed ID: 37934800
[TBL] [Abstract][Full Text] [Related]
2. Post-COVID syndrome, inflammation, and diabetes.
Rizvi AA; Kathuria A; Al Mahmeed W; Al-Rasadi K; Al-Alawi K; Banach M; Banerjee Y; Ceriello A; Cesur M; Cosentino F; Galia M; Goh SY; Janez A; Kalra S; Kempler P; Lessan N; Lotufo P; Papanas N; Santos RD; Stoian AP; Toth PP; Viswanathan V; Rizzo M;
J Diabetes Complications; 2022 Nov; 36(11):108336. PubMed ID: 36228563
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 perturbs the renin-angiotensin system and energy metabolism.
Mori J; Oudit GY; Lopaschuk GD
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E43-E47. PubMed ID: 32469255
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 and diabetes mellitus: a review of the incidence, pathophysiology and management of diabetes during the pandemic.
Faruqi J; Balasubramanyam A
Expert Rev Endocrinol Metab; 2023 Mar; 18(2):167-179. PubMed ID: 36797835
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1.
Shin J; Toyoda S; Nishitani S; Onodera T; Fukuda S; Kita S; Fukuhara A; Shimomura I
Metabolism; 2022 Aug; 133():155236. PubMed ID: 35688210
[TBL] [Abstract][Full Text] [Related]
6. Unwinding Link between Coronavirus and Diabetes Patient.
Bhadauria SS; Malviya R; Sharma PK
Endocr Metab Immune Disord Drug Targets; 2022; 22(11):1091-1110. PubMed ID: 35352656
[TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanisms Responsible for Diabetogenic Effects of COVID-19 Infection-Induction of Autoimmune Dysregulation and Metabolic Disturbances.
Grubišić B; Švitek L; Ormanac K; Sabo D; Mihaljević I; Bilić-Ćurčić I; Omanović Kolarić T
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511334
[TBL] [Abstract][Full Text] [Related]
8. Caring for Hospitalized Patients with Diabetes Mellitus, Hyperglycemia, and COVID-19: Bridging the Remaining Knowledge Gaps.
Wallia A; Prince G; Touma E; El Muayed M; Seley JJ
Curr Diab Rep; 2020 Nov; 20(12):77. PubMed ID: 33244614
[TBL] [Abstract][Full Text] [Related]
9. Exploring the Network between Adipocytokines and Inflammatory Response in SARS-CoV-2 Infection: A Scoping Review.
Nigro E; D'Agnano V; Quarcio G; Mariniello DF; Bianco A; Daniele A; Perrotta F
Nutrients; 2023 Aug; 15(17):. PubMed ID: 37686837
[TBL] [Abstract][Full Text] [Related]
10. Interactions between COVID-19 infection and diabetes.
Heshmati HM
Front Endocrinol (Lausanne); 2023; 14():1306290. PubMed ID: 38292772
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 and Diabetes Mellitus: Mutual Interplay of Two Diseases.
Krumpolec P; Kodada D; Nyáriová N; Repiská V; Minárik G
Curr Diabetes Rev; 2023; 19(9):e130922208761. PubMed ID: 36100987
[TBL] [Abstract][Full Text] [Related]
12. Challenging Issues in the Management of Cardiovascular Risk Factors in Diabetes During the COVID-19 Pandemic: A Review of Current Literature.
Rahimi L; Malek M; Ismail-Beigi F; Khamseh ME
Adv Ther; 2020 Aug; 37(8):3450-3462. PubMed ID: 32632851
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course.
Landstra CP; de Koning EJP
Front Endocrinol (Lausanne); 2021; 12():649525. PubMed ID: 34220706
[TBL] [Abstract][Full Text] [Related]
14. Increased Risk of COVID-19 in Patients with Diabetes Mellitus-Current Challenges in Pathophysiology, Treatment and Prevention.
Gęca T; Wojtowicz K; Guzik P; Góra T
Int J Environ Res Public Health; 2022 May; 19(11):. PubMed ID: 35682137
[TBL] [Abstract][Full Text] [Related]
15. New-Onset Diabetes After COVID-19.
Kim SH; Arora I; Hsia DS; Knowler WC; LeBlanc E; Mylonakis E; Pratley R; Pittas AG
J Clin Endocrinol Metab; 2023 Oct; 108(11):e1164-e1174. PubMed ID: 37207448
[TBL] [Abstract][Full Text] [Related]
16. Diabetes in the COVID-19 pandemic era.
Bonansea TCP; Santos LPD; Zintl K; Souza ACDS
Rev Assoc Med Bras (1992); 2021; 67Suppl 1(Suppl 1):157-162. PubMed ID: 34406303
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the link between Diabetes mellitus and SARS-CoV-2 infection through differential targeting of microRNAs in the human pancreas.
Bhavya ; Pathak E; Mishra R
J Endocrinol Invest; 2022 Mar; 45(3):537-550. PubMed ID: 34669152
[TBL] [Abstract][Full Text] [Related]
18. Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management.
Vallianou NG; Evangelopoulos A; Kounatidis D; Stratigou T; Christodoulatos GS; Karampela I; Dalamaga M
Curr Diabetes Rev; 2021; 17(6):e123120189797. PubMed ID: 33388022
[TBL] [Abstract][Full Text] [Related]
19. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19.
El-Missiry MA; El-Missiry ZMA; Othman AI
Eur J Pharmacol; 2020 Sep; 882():173329. PubMed ID: 32615182
[TBL] [Abstract][Full Text] [Related]
20. Obesity, Diabetes and COVID-19: An Infectious Disease Spreading From the East Collides With the Consequences of an Unhealthy Western Lifestyle.
Holly JMP; Biernacka K; Maskell N; Perks CM
Front Endocrinol (Lausanne); 2020; 11():582870. PubMed ID: 33042029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
